Testing Nemtabrutinib in People with Severe Kidney Disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new medicine (nemtabrutinib) in people with severe kidney disease to see how the body handles it. The study helps doctors decide safe doses for people with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe kidney disease (severe renal impairment).
- Your kidney function has been stable, as shown by recent medical tests.
- You do not have other major illnesses besides kidney disease that could confuse the results or add risk.
- Your body mass index (BMI) is between 18 and 40.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This Phase 2 trial tests nemtabrutinib (MK-1026), an oral medicine, in people with certain blood cancers that have come back or didn’t respond to earlier treatments. It aims to see how well the drug works and whether it is safe.
This study tests a new oral medication, nemtabrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that did not respond to or stopped responding to certain targeted therapies. The medication aims to control the disease when other options have not worked.
This study looks at how a medicine called rilzabrutinib (taken as a tablet) is processed in the body when the kidneys are severely damaged compared to when they work normally. It helps researchers understand if the dose needs to be adjusted for people with kidney problems.
Hear when a new Severe Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.